Experiences with F-32 in advanced carcinoma of the prostate.
D000368:Aged; D000740:Anemia / Q000209:etiology; D001859:Bone Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D002277:Carcinoma / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010759:Phosphorus Isotopes / Q000009:adverse effects / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D013117:Spinal Cord Compression / Q000139:chemically induced; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use
D009294:Narcotics; D010759:Phosphorus Isotopes; D013739:Testosterone